ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
DiscGenics treates First Patients in Japanese Clinical Trial of Cell Therapy for DDD
August 08, 2019The prospective, randomized, double-blinded, sham-controlled study is designed to evaluate the safety and preliminary efficacy of IDCT at two dosage levels in subjects with single-level, symptomatic lumbar DDD, a major cause of chronic low back pain -
InterVenn BioSciences Enrolls First Patients in VOCAL Trial
June 05, 2019New ovarian cancer test combines AI and Mass Spec in an effort to better identify cancerous ovarian tumors from benign ones through a simple blood draw
Pharma Sources Insight January 2025
